Share

Linde plc (LIN.NYSE) AI OPINIONS & ADVISOR ANALYSIS

Read and compare the 14 individual AI Advisor deep-dive reports, including their forecast paths, ratings, price targets, and reasoning.

Updated on 20 September 2026Deep analysis 20 September 2026

Publisher

Russlan Ramdowar

25 min readAudit All Past Forecasts

14 AI Advisor Reports

Select an advisor report.

SynthesizerCombines all advisor views

Synthesis of 14 independent opinions

Diversity of ModelsSame approach, varied models

Diversity of FrameworksDifferent investing styles

AI Researcher

Opus 5

Universal Investor AI

The Polymath Framework

Model rating

Neutral

5-Year Return Est.

+52.1%

Includes 0.94% annual net dividend contribution

1. Investment Thesis — Base Case

Linde is a toll road on industrial oxygen, nitrogen and hydrogen, where fifteen-year onsite contracts make volume someone else's problem. The central tension is not whether earnings compound - price plus productivity plus buybacks deliver roughly 8% almost regardless of the cycle - but what investors pay for that compounding when Treasuries yield 5%. Over five years I expect the earnings engine to hold and the multiple to drift lower, from roughly 26x forward toward 23x. That combination produces respectable, unspectacular returns: growth delivered, premium partially surrendered. Investors are buying certainty at a fair, not generous, price.

FY26 adjusted EPS midpoint of $17.80 compounding near 8% annually reaches roughly $26 by 2031.
At 23-24x forward earnings, that implies a share price near $650 against $460 today.
Cross-check: $214B market cap, 17.6x EV/EBITDA, with buybacks retiring about 2% of shares yearly.

Historical prices and published forecast

Observed price
Published advisor forecast

Observed prices and the selected advisor's published projection share a split-adjusted price basis. Prices after the forecast start are later observations, not information known at publication. Forecasts are uncertain. Values in USD.

View chart values

Historical prices and published forecast — published chart values
Series	Date	Value (USD)
Observed price	2021-09-14	312
Observed price	2021-09-30	293
Observed price	2021-10-12	296
Observed price	2021-10-28	318
Observed price	2021-11-01	323
Observed price	2021-11-09	339
Observed price	2021-11-29	319
Observed price	2021-12-15	337
Observed price	2021-12-19	333
Observed price	2021-12-31	346
Observed price	2022-01-12	341
Observed price	2022-01-28	313
Observed price	2022-02-09	304
Observed price	2022-02-21	296
Observed price	2022-03-05	279
Observed price	2022-03-21	311
Observed price	2022-03-29	326
Observed price	2022-04-06	315
Observed price	2022-04-22	322
Observed price	2022-05-08	303
Observed price	2022-05-12	305
Observed price	2022-05-28	328
Observed price	2022-06-05	334
Observed price	2022-06-17	291
Observed price	2022-06-29	290
Observed price	2022-07-07	274
Observed price	2022-07-23	288
Observed price	2022-08-12	312
Observed price	2022-08-16	312
Observed price	2022-09-05	277
Observed price	2022-09-13	291
Observed price	2022-09-25	267
Observed price	2022-10-11	272
Observed price	2022-10-19	283
Observed price	2022-10-27	298
Observed price	2022-11-16	331
Observed price	2022-11-24	342
Observed price	2022-12-06	332
Observed price	2022-12-14	342
Observed price	2023-01-03	318
Observed price	2023-01-07	314
Observed price	2023-01-15	330
Observed price	2023-02-08	335
Observed price	2023-02-20	327
Observed price	2023-03-08	355
Observed price	2023-03-16	338
Observed price	2023-03-20	339
Observed price	2023-04-09	358
Observed price	2023-04-13	360
Observed price	2023-04-29	370
Observed price	2023-05-11	370
Observed price	2023-05-27	356
Observed price	2023-05-31	354
Observed price	2023-06-16	375
Observed price	2023-07-06	365
Observed price	2023-07-14	379
Observed price	2023-07-30	389
Observed price	2023-08-03	381
Observed price	2023-08-19	377
Observed price	2023-08-31	387
Observed price	2023-09-16	388
Observed price	2023-09-24	376
Observed price	2023-10-06	371
Observed price	2023-10-14	379
Observed price	2023-10-22	367
Observed price	2023-11-11	401
Observed price	2023-11-27	413
Observed price	2023-12-05	404
Observed price	2023-12-09	403
Observed price	2023-12-25	410
Observed price	2024-01-02	410
Observed price	2024-01-10	406
Observed price	2024-01-26	404
Observed price	2024-02-15	425
Observed price	2024-02-19	436
Observed price	2024-03-10	467
Observed price	2024-03-14	474
Observed price	2024-04-03	459
Observed price	2024-04-07	461
Observed price	2024-04-27	443
Observed price	2024-05-05	425
Observed price	2024-05-21	434
Observed price	2024-05-29	426
Observed price	2024-06-14	437
Observed price	2024-06-22	442
Observed price	2024-06-30	432
Observed price	2024-07-12	441
Observed price	2024-08-01	453
Observed price	2024-08-05	444
Observed price	2024-08-25	469
Observed price	2024-09-02	474
Observed price	2024-09-10	464
Observed price	2024-09-26	478
Observed price	2024-10-08	466
Observed price	2024-10-20	484
Observed price	2024-11-01	457
Observed price	2024-11-17	450
Observed price	2024-11-29	461
Observed price	2024-12-03	458
Observed price	2024-12-19	420
Observed price	2025-01-04	414
Observed price	2025-01-16	432
Observed price	2025-01-28	436
Observed price	2025-02-09	458
Observed price	2025-02-25	460
Observed price	2025-03-01	466
Observed price	2025-03-09	463
Observed price	2025-03-13	453
Observed price	2025-04-02	467
Observed price	2025-04-06	436
Observed price	2025-04-26	449
Observed price	2025-05-16	458
Observed price	2025-05-20	460
Observed price	2025-06-09	475
Observed price	2025-06-21	459
Observed price	2025-07-03	476
Observed price	2025-07-15	464
Observed price	2025-07-23	472
Observed price	2025-07-31	463
Observed price	2025-08-20	480
Observed price	2025-08-28	481
Observed price	2025-09-05	470
Observed price	2025-09-17	480
Observed price	2025-10-03	467
Observed price	2025-10-11	457
Observed price	2025-10-31	418
Observed price	2025-11-12	429
Observed price	2025-11-24	408
Observed price	2025-12-10	397
Observed price	2025-12-18	422
Observed price	2025-12-22	424
Observed price	2026-01-11	443
Observed price	2026-01-19	439
Observed price	2026-02-04	473
Observed price	2026-02-08	454
Observed price	2026-02-28	506
Observed price	2026-03-04	496
Observed price	2026-03-24	485
Observed price	2026-04-13	509
Observed price	2026-04-17	492
Observed price	2026-04-25	509
Observed price	2026-05-07	494
Observed price	2026-05-23	515
Observed price	2026-05-31	499
Observed price	2026-06-08	514
Observed price	2026-06-28	519
Observed price	2026-07-02	547
Observed price	2026-07-22	509
Observed price	2026-07-26	509
Observed price	2026-08-15	480
Observed price	2026-08-31	490
Observed price	2026-09-08	468
Observed price	2026-09-21	458
Observed price	2026-09-23	470
Observed price	2026-09-25	470
Published advisor forecast	2026-09-18	460
Published advisor forecast	2026-12-18	470
Published advisor forecast	2027-03-18	484
Published advisor forecast	2027-06-18	474
Published advisor forecast	2027-09-18	493
Published advisor forecast	2027-12-18	503
Published advisor forecast	2028-03-18	518
Published advisor forecast	2028-06-18	528
Published advisor forecast	2028-09-18	512
Published advisor forecast	2028-12-18	533
Published advisor forecast	2029-03-18	549
Published advisor forecast	2029-06-18	560
Published advisor forecast	2029-09-18	571
Published advisor forecast	2029-12-18	588
Published advisor forecast	2030-03-18	600
Published advisor forecast	2030-06-18	612
Published advisor forecast	2030-09-18	600
Published advisor forecast	2030-12-18	624
Published advisor forecast	2031-03-18	636
Published advisor forecast	2031-06-18	649
Published advisor forecast	2031-09-18	668

2. Scenarios & Signals

Bull case

The bull case activates when disinflation and a Lincare exit arrive together. Falling policy rates lift the multiple that a 2.3% free-cash-flow-yield compounder commands, while divesting homecare removes the identified margin leak and funds accelerated repurchases. Electronics backlog conversion then proves the growth is higher-quality than chemicals-heavy history implies, and margins resume their 100-bps annual climb. Earnings compound at the top of the 8-12% range against a re-expanding 28x multiple, delivering total returns well above 60%.

Bear case

The bear case activates when sticky inflation meets a chemical downturn. A funds rate near 4.5% through 2028 pushes capital toward yield-bearing alternatives, de-rating Linde toward 20x forward, while recession stalls the chemicals 56% of backlog and defers start-ups. Rising capex commitments then collide with softer cash generation, forcing buybacks down just as the multiple contracts. Clean-energy cancellations echoing Louisiana and Baytown compound the narrative damage, leaving the shares below today's price despite positive earnings growth.

Current crowd narrative

The consensus treats Linde as the industrial-gas annuity that always delivers: 27 analysts rate it Buy with an average target of $544.54, KeyBanc initiating Overweight at $542 [12][1]. The anchoring bias is the 8-12% algorithm, assumed near-mechanical. Priced in: record $11B , 8-9% FY26 EPS growth, Lincare fixed. Barely priced in: that the multiple, not the earnings, is what moved.

Alpha-gap assessment

No convincing gap exists in either direction - the shares are close to fairly priced, which is itself the finding. The crowd correctly values the earnings engine but conflates two things: 8-9% is durable, while 26x forward is not a constant. The overlooked evidence cuts both ways - electronics quality is underappreciated, while the 57% "clean energy" label masks blue-hydrogen offtake fragility after Louisiana and Baytown [14][15]. Expect earnings-driven returns, not multiple-driven ones.

Convergence catalyst

A Lincare resolution is the cleanest trigger: a 2027 announcement removes the identified 30-bps margin leak and redeploys proceeds into buybacks. The first observable sign is Americas adjusted margin returning above 31.5% in a quarterly print, which would restore the clean compounding narrative the market pays a premium for.

Paywalled preview begins: Macro-regime alignment

From this section to the end-of-preview notice below, research is provided as simplified HTML text and tables. Full access provides the complete interactive interface, charts and additional datasets.

Sentiment and regime

Greed and fear sentiment: -0.1
Expected volatility regime: moderate
Convergence-cycle position: reversal

Primary drivers

Primary drivers supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Advanced NODE FABS BUY THE GAS	Electronics is now 22% of a record $8.1B sale-of-gas backlog, enlarged by a $1B win serving advanced-node fabs in the western US, with roughly $800M more through the Taiwan LienHwa venture sitting outside it [7][8]. Asia Pacific sales rose 13% in Q2 2026 [4]. Semiconductor onsite contracts are 15-year, take-or-pay-style annuities, so AI-driven fab construction converts into decade-long volume and 23.5%-return capital deployment.	Not available	+22.0%
Pricing THAT Outruns Inflation	Linde's Q2 2026 underlying 4% growth split evenly between price and volume [6], and pricing has exceeded local inflation in every cycle since the Praxair merger because onsite contracts embed energy pass-through and merchant/packaged gas is a duopoly-adjacent, freight-protected local market. With Brent near $104 and TTF at EUR 79.52/MWh, pass-through inflates revenue while protecting absolute profit. This pricing architecture persists as long as regional density holds.	Not available	+18.0%
THE Relentless Productivity Ratchet	Operating margin climbed from 14.3% in 2020 to 26.3% in 2025 on a reported basis, with adjusted operating margin at 29.5% in Q2 2026 [4][9]. This is not cyclical luck: it is annual cost-productivity targets, plant-loading discipline and decentralised accountability applied to a fixed-asset base. Each 100 bps of margin on $35.4B TTM revenue is roughly $350M of pre-tax profit, and management reaffirms 8-12% EPS growth without macro help [8].	Not available	+15.0%
Share Count Shrinks Dividend Climbs	Linde returned $3.1B in H1 2026, $1.4B dividends and $1.7B net repurchases [2], consistent with the 1.35% TTM dividend yield and 1.90% net buyback yield. Repurchases at roughly 2% of shares annually convert mid-single-digit operating growth into high-single-digit EPS growth, and the quarterly dividend of $1.60 is covered roughly two-and-a-half times by free cash flow. Capital discipline is the most reliable part of this algorithm.	Not available	+13.0%

Primary frictions

Primary frictions supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Discount Rates TAX THE Compounder	The 10-year Treasury closed at 4.998% and the Fed's September median implies a further hike [context]. Linde's 2.33% TTM free-cash-flow yield and 29.3x trailing earnings were underwritten in a cheaper-money world; each sustained 50 bps of real-rate increase compresses the terminal multiple that bond-proxy quality names command. The de-rating is already visible: shares trade roughly 15% below the 52-week high of $548.20 despite rising earnings [1].	Not available	-15.0%
Capex UP FREE CASH FLOW Squeezed	Full-year 2026 capex guidance rose to $5.5-6.0B from the $5.0-5.5B signalled at Q1 [4][11], against roughly $3.8B of depreciation. Q2 free cash flow was $833M after $1,438M of capex [4]. The spending is contracted and return-accretive at 23.5% project returns, but it holds reported free-cash-flow yield at 2.33% versus a 5% risk-free alternative, constraining buyback capacity and the multiple investors will pay.	Not available	-9.0%
Clean Energy's Shrinking 57%	Linde classifies 57% of its sale-of-gas backlog as clean energy [7], yet the North American blue-hydrogen ecosystem is contracting: Air Products wrote off $2.9B in Louisiana, Exxon paused Baytown in June 2026 for want of offtake, and Blue Point stands nearly alone [14][15][16]. Linde's $1.8B autothermal reformer sits inside that ecosystem. Take-or-pay protects operating assets, but pre-start-up cancellation delays backlog conversion and erodes the growth narrative investors pay for.	Not available	-8.0%
Lincare THE Margin LEAK	Q2 2026 operating margin fell 60 bps year over year, 30 bps excluding pass-through, driven primarily by US homecare; Americas margins would have risen 20 bps without it [10]. Labour-cost inflation and reimbursement changes have broken Lincare's unit economics, and management now reviews its fit "in part and as a whole". Shares fell 5.15% to $416.40 on that print [9], proving the market prices Linde on margin trajectory, not revenue optics.	Not available	-6.0%

Tail opportunities

Tail opportunities supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
AI FABS Become THE NEW Backlog Engine	If the western-US fab win and the ~$800M Taiwan LienHwa investment [7] prove to be the first of a wave, electronics could climb from 22% toward 35% of a sale-of-gas backlog exceeding $12B by 2028-29. Semiconductor onsite plants carry higher returns, shorter build cycles and creditworthy counterparties than chemicals, which would raise both the growth rate and the quality of the growth - the two inputs that set the multiple. Below 50% because fab capex is itself cyclical and depends on AI demand persisting through a tightening cycle.	35.0%	+18.0%
Lincare EXIT Resets THE Margin Story	Management's admission that it is evaluating US homecare "in part and as a whole" [10] points to a 2027 disposal. A sale at even a mid-single-digit EBITDA multiple would release several billion dollars for buybacks while removing the single identified drag on Americas margins, restoring the clean 100-bps-a-year expansion narrative that justified a 30x multiple. Expect announcement in 2027 and re-rating within two quarters of closing. It stays below 50% because carve-outs of regulated healthcare assets are slow, buyers are scarce and impairment could sour the optics.	40.0%	+14.0%

Tail risks

Tail risks supplied in this advisor's published forecast
Force	Rationale	Probability	Expected price impact
Chemical Cycle Breaks THE Volume Engine	Chemicals represent 56% of the sale-of-gas backlog [7] and merchant volumes track ethylene, refining and steel. A 2027-28 recession driven by Fed tightening into an unresolved energy shock - Brent near $104, Hormuz and Saudi export routes disrupted [context] - would delay start-ups and turn underlying volumes negative. Earnings would still grind higher on price and buybacks, but the 8-12% algorithm would visibly break and the multiple would compress toward 20x. Below 50% because take-or-pay contracts historically cushion Linde through downturns.	33.0%	-24.0%
BOND Proxy Repricing TO Twenty Times	If core inflation stays above 3% and the funds rate settles near 4.5% into 2028, capital rotates out of defensive compounders toward instruments yielding more than Linde's 2.33% free-cash-flow yield. A de-rating from roughly 26x forward to 20x costs about 23% of price even with earnings compounding at 8%. The trigger would be consecutive upside CPI prints plus a hawkish 2027 dot plot. Below 50% because the Fed's own September median projects PCE inflation easing to 2.3% by 2027.	30.0%	-20.0%

Step-by-step forecast path

Universal Investor forecast path for prediction task predrqst_batch_task__xrefsubjtskconf_f777ae56-e2b0-51de-bf60-d63b3e301297__sb7__20260920064920277661
Step	Forecast date	Step change	Projected value (USD)	Scenario rationale
1	December 18, 2026	+2.0%	469.61	Q3 results in late October should land within the $4.45-4.55 guidance and confirm backlog above $8B, but a 5% 10-year yield caps re-rating. Modest gain on delivery, not enthusiasm.
2	March 18, 2027	+3.0%	483.70	FY26 close near $17.80 EPS plus initial FY27 guidance around 8-9% growth reassures. Over twenty H2 start-ups worth $1.3B begin contributing volume, offsetting the higher capex guide.
3	June 18, 2027	-2.0%	474.02	European industrial weakness and Chinese fixed-investment contraction show through in merchant volumes. Energy pass-through flatters revenue while diluting percentage margins, prompting a small de-rating on quality-of-growth doubts.
4	September 18, 2027	+4.0%	492.98	Progress on the homecare strategic review, plus Americas margins recovering toward 31.5%, restores the clean compounding narrative. Electronics backlog conversion from western-US fabs adds credible volume visibility.
5	December 18, 2027	+2.0%	502.84	Easing inflation reduces the discount-rate headwind modestly. Year-end backlog additions in semiconductors offset chemicals softness; buybacks near 2% of shares continue supporting per-share economics.
6	March 18, 2028	+3.0%	517.93	FY28 guidance holds the 8-12% algorithm with capex plateauing after the 2026-27 build cycle. Free-cash-flow yield improves as start-ups convert spending into contracted revenue.
7	June 18, 2028	+2.0%	528.29	Steady quarter: price-led growth of roughly 2% with flat base volumes. Taiwan LienHwa capacity begins contributing to Asia Pacific, the fastest-growing region at low-double-digit sales growth.
8	September 18, 2028	-3.0%	512.44	A cyclical air pocket in chemicals, 56% of backlog, delays project start-ups and pressures merchant volumes. Defensive quality limits the drawdown but the multiple compresses on growth doubts.
9	December 18, 2028	+4.0%	532.94	Recovery as deferred start-ups resume and cost-productivity programmes protect margins through the soft patch. Absolute earnings still grow, vindicating the take-or-pay contract structure to sceptical investors.
10	March 18, 2029	+3.0%	548.92	Post-Lincare portfolio shows cleaner Americas margins. Blue Point ammonia commissioning validates at least part of the clean-energy backlog that Louisiana and Baytown cancellations had discredited.
11	June 18, 2029	+2.0%	559.90	Normalising policy rates ease the bond-proxy discount. Electronics rises toward a third of backlog, improving counterparty quality and shortening build cycles relative to chemicals projects.
12	September 18, 2029	+2.0%	571.10	Mid-cycle steadiness: pricing above local inflation, productivity gains, and roughly 2% annual share-count reduction combine into high-single-digit EPS growth with an unchanged forward multiple.
13	December 18, 2029	+3.0%	588.23	Capex-to-revenue normalises below 14% as the build cycle matures, lifting free-cash-flow yield above 3%. Improved cash conversion supports larger repurchases and a firmer valuation floor.
14	March 18, 2030	+2.0%	600.00	FY30 guidance sustains the algorithm. Hydrogen economics improve selectively where offtake is contracted, though the sector remains smaller than 2025-era projections implied.
15	June 18, 2030	+2.0%	612.00	Semiconductor gas demand from advanced packaging and next-generation fabs keeps Asia Pacific the growth leader. European volumes remain the drag, dependent on persistent energy-cost disadvantage.
16	September 18, 2030	-2.0%	599.76	Rotation away from defensives during a risk-on phase trims the multiple. Fundamentals unchanged; the move reflects relative positioning rather than any deterioration in contracted cash flows.
17	December 18, 2030	+4.0%	623.75	Backlog replenishment beyond $12B, weighted toward electronics and decarbonisation projects with firm offtake, re-establishes visible growth into the 2030s and attracts long-duration capital.
18	March 18, 2031	+2.0%	636.22	EPS approaches the mid-twenties per share with the forward multiple settled near 23x. Compounding, not re-rating, now drives returns - the mature phase of this thesis.
19	June 18, 2031	+2.0%	648.95	Dividend growth continues alongside steady buybacks. Industrial-gas oligopoly pricing discipline holds, with regional density still deterring entry in merchant and packaged markets.
20	September 18, 2031	+3.0%	668.42	Horizon close near $668, roughly 24x forward earnings of about $28. Returns derived from earnings compounding and share-count reduction, with modest net multiple compression from today.

Advisor and configuration

Advisor: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release
Persona: Universal Investor
Archetype: The Polymath
Model: 2026-07-24 release
Provider: Anthropic
Mode: RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity
Task configuration: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release__equity__json__extnd_invest_thesis_4q_alphassym__ts_num_desc__h5y_s3m__var1__researcher__standard_creativity_high_thinking__batch
Forecast horizon: 5 year
Forecast steps: 20 steps of 3 month
Assembly type: Balanced Assembly
Assembly name: universal_investor__the_polymath__anthropic_claude_opus_5__20260724_release RESEARCHER Forecast Assembly
Input format: inmemory_base_placeholders__latest_eod_close_price_with_stats_and_fundamentals__var1
Output format: Equity Extended Investment Thesis (4 Quadrants and Alpha Asymmetry) + Pct Change Timeseries for Close Price with Rationale, (5Y Quarterly)

Read the complete Universal Investor advisor methodology

Configuration components

aiassmprmtcmpnt_b995bbe2-6a15-55be-a576-525904f696e8
aiassmprmtcmpnt_c55d1851-d218-5d30-b83b-54bbda31e2ee
aiassmprmtcmpnt_930157b1-05d7-5699-bf0a-738645ee42fd
aiassmprmtcmpnt_3c0c459a-0d4a-50ca-87df-c172ec5618aa
aiassmprmtcmpnt_8115cc2a-d418-54b1-a616-49dfa91195f4

Research sources

[1]Linde stock gains backing as KeyBanc sets USD 542 targetad-hoc-news.de
[2]Linde plc stock gains support as analysts highlight guidance and cash returnsad-hoc-news.de
[3]Linde stock gains analyst support with KeyBanc overweight rating and USD 542 targetad-hoc-news.de
[4]Linde (Nasdaq: LIN) grows Q2 EPS 11% and builds $11B project backlogstocktitan.net
[5]Linde Reports Second-Quarter 2026 Results | Nasdaqnasdaq.com
[6]LINDE PLC - Form 8-K - FY2026sec.gov
[7]Linde Adds $1 Billion Phoenix Semiconductor Gas Expansion as Project Backlog Reaches $11.1 Billion - Downstream Calendardownstreamcalendar.com
[8]Linde (LIN) Q2 2026 Earnings Call Transcript | The Motley Foolfool.com
[9]Linde Q2 2026 slides: record backlog amid margin pressure By Investing.cominvesting.com
[10]HME News • September 2026 • LINCARE DRAWS SCRUTINYdigital.hmenews.com
[11]lin_ex991.htmsec.gov
[12]Linde (LIN) Stock Forecast & Analyst Price Targetsstockanalysis.com
[13]Linde (LIN) Stock Price & Overviewstockanalysis.com
[14]Woodside blue ammonia plant stumbles, though CF moves aheadcen.acs.org
[15]Exxon Mobil Hydrogen 2026, $3.7B DOE Cut, BP Pause - EnkiAIenkiai.com
[16]Blue Point Breaks Ground: What Changes Now It's | decarbonfuse.comdecarbonfuse.com
[17]Linde (LIN) - Fundamental Analysis Report 2026 (Updated)deepresearchglobal.com

Back to advisor navigation

End of the paywalled preview

The excerpt from Macro-regime alignment to this notice is the simplified paywalled content included on this page. A signed-in, verified account with the required subscription provides the full interactive interface and the additional research, datasets and tools listed below.

Those additional materials are not included in this preview and cannot be revealed by removing its visual restrictions.

Other AI Advisor reports — limited previews

Niccolo Machiavelli — RESEARCHER (Web Search Enabled) with High Reasoning and Standard Creativity

Gemini 3.8 Flash

Limited structural preview, provided as simplified HTML. The complete report contains substantially more research: its investment thesis; bull and bear scenarios; macro-regime analysis; drivers, risks and opportunities; quarterly forecast tables and rationale; references and published configuration. Those findings and datasets are not included here. Sign in with the required subscription to open this advisor's full report.